Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163434 | SCV000213980 | likely benign | Hereditary cancer-predisposing syndrome | 2018-12-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000226709 | SCV000291455 | benign | Birt-Hogg-Dube syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000374324 | SCV000401004 | likely benign | Familial spontaneous pneumothorax | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000226709 | SCV000401005 | likely benign | Birt-Hogg-Dube syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000034797 | SCV000724487 | likely benign | not provided | 2021-08-19 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28873162, 24728327, 22703879, 14627671, 27146957, 20522427, 21794948) |
Sema4, |
RCV000163434 | SCV002532385 | likely benign | Hereditary cancer-predisposing syndrome | 2020-10-22 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000121114 | SCV002551343 | uncertain significance | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000121114 | SCV002774745 | benign | not specified | 2021-06-25 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000226709 | SCV004018702 | benign | Birt-Hogg-Dube syndrome | 2023-07-06 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. Homozygosity has been confirmed in one or more individuals. As homozygosity for pathogenic variants in this gene is generally assumed to result in embryonic lethality, this variant is unlikely to be pathogenic. |
Ce |
RCV000034797 | SCV004142320 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | FLCN: BP4, BS1 |
Breakthrough Genomics, |
RCV000034797 | SCV005212263 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Biesecker Lab/Clinical Genomics Section, |
RCV000034797 | SCV000043265 | variant of unknown significance | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Uncertain significance. |
ITMI | RCV000121114 | SCV000085282 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Genome Diagnostics Laboratory, |
RCV000034797 | SCV001809541 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000034797 | SCV001953426 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003952399 | SCV004772529 | likely benign | FLCN-related disorder | 2020-09-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |